Internal Medicine, Rheumatology · Apple Valley, CA
NPI
1669402467
Since 2006
Specialty
Internal Medicine, Rheumatology
Code 207RR0500X
Group practices
2
Medicare group memberships
Hospitals
3
Hospital affiliations
16143 Kokanee Rd Suite C
Apple Valley, CA, 92307
Phone (760) 242-6442
Groups this clinician bills Medicare through
Medicare paid, 2024
$119K
2,383 services
Medicare patients, 2024
531
Average age 68
Drug cost, 2024
$14.3M
23,044 prescriptions
Company payments, 2025
$4,165
From 18 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Bikramjit S Ahluwalia was code 99213 (office e&m - established), 1,406 times for 480 patients. In total Bikramjit S Ahluwalia billed 2,383 services in 18 codes, and Medicare paid $119K.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2015-02-12.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| 99213 Office E&M - Established | Office | 1,406 | 480 | $53.17 | $75K |
| 99232 Hospital E&M - Subsequent | Facility | 221 | 49 | $55.96 | $12K |
| 99214 Office E&M - Established | Office | 86 | 72 | $75.22 | $6,469 |
| 99203 Office E&M - New | Office | 59 | 59 | $60.01 | $3,541 |
| 99223 Hospital E&M - Initial | Facility | 46 | 43 | $121.24 | $5,577 |
| 99238 Hospital Discharge Management | Facility | 29 | 26 | $58.05 | $1,683 |
| 20610 Joint Injection | Office | 15 | 14 | $54.27 | $814 |
| J2001 Injection, lidocaine hcl for intravenous infusion, 10 mg | Office | 13 | 12 | $0.02 | $0.26 |
By year: 2022 $155K for 3,198 services; 2023 $130K for 2,670 services; 2024 $119K for 2,383 services.
Medicare prescription drug claims, 2024
In 2024, the drug Bikramjit S Ahluwalia prescribed most often to Medicare patients was Hydroxychloroquine Sulfate, with 1,328 prescriptions and refills. In total Bikramjit S Ahluwalia wrote 23,044 Medicare prescriptions that cost $14.3M.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Hydroxychloroquine Sulfate Generic | 1,328 | 1,988 | 297 | $27K |
| Methotrexate Methotrexate Sodium | 1,316 | 1,788 | 263 | $22K |
| Atorvastatin Calcium Generic | 1,045 | 2,182 | 329 | $11K |
| Gabapentin Generic | 732 | 942 | 165 | $8,235 |
| Lisinopril Generic | 558 | 1,134 | 166 | $3,669 |
| Levothyroxine Sodium Generic | 551 | 986 | 137 | $4,989 |
| Amlodipine Besylate Generic | 530 | 1,014 | 151 | $2,727 |
| Leflunomide Generic | 496 | 797 | 122 | $28K |
| Omeprazole Generic | 464 | 823 | 119 | $4,058 |
| Rinvoq Upadacitinib | 430 | 440 | 68 | $2.8M |
| Metformin Hcl Generic | 426 | 892 | 128 | $2,986 |
| Prednisone Generic | 417 | 495 | 114 | $1,681 |
| Pantoprazole Sodium Generic | 391 | 632 | 110 | $3,924 |
| Humira(Cf) Pen Adalimumab | 377 | 377 | 46 | $2.7M |
| Losartan Potassium Generic | 357 | 765 | 119 | $3,083 |
Brand drugs: 4,573 claims; generic drugs: 18,280 claims; opioid claims: 275.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Bikramjit S Ahluwalia $4,165 ($4,165 in general payments such as food, travel and fees) from 18 companies. The largest payer was Abbvie Inc. with $957.
| Company | Payments | Amount |
|---|---|---|
| Abbvie Inc. ABBV | 63 | $957 |
| UCB, Inc. UCB.BR | 23 | $590 |
| AstraZeneca Pharmaceuticals LP AZN | 21 | $518 |
| Amgen Inc. AMGN | 25 | $493 |
| Janssen Biotech, Inc. JNJ | 20 | $292 |
| Novartis Pharmaceuticals Corporation NVS | 17 | $271 |
| Novo Nordisk Inc NVO | 11 | $198 |
| Mallinckrodt Hospital Products Inc. | 12 | $146 |
| Pfizer Inc. PFE | 10 | $137 |
| Aurinia Pharma U.S., Inc. AUPH | 5 | $111 |
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.